1 | ( L ) ASCORBATO DI CALCIO | 1件: Calcium Calcium | - | - | - | 2件: 96 96, 97 💬
|
2 | (-)-3-(4-Aminophenyl)-2-methoxypropionic acid | - | - | - | - | 1件: 97 97 💬
|
3 | (R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid | 2件: Butyric Acid Butyric Acid, Chloride ion | - | - | - | 1件: 97 97 💬
|
4 | (S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid | - | - | - | - | 1件: 97 97 💬
|
5 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | 1件: 97 97 💬
|
6 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben | - | - | - | - | 1件: 97 97 💬
|
7 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | 1件: 97 97 💬
|
8 | * D.3.4 Solution for infusion in pre-filled syringe | - | - | - | - | 1件: 97 97 💬
|
9 | * D.3.4 Solution for injection in pre-filled syringe | - | - | - | - | 1件: 97 97 💬
|
10 | * D.3.4 Solution for injection/infusion in pre-filled syringe | - | - | - | - | 1件: 97 97 💬
|
11 | -aminosalicylic acid | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | 2件: 96 96, 97 💬
|
12 | 0.25 mg RPC103 | - | - | - | - | 1件: 97 97 💬
|
13 | 0.25 mg RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
14 | 0.25mg RPC103 | - | - | - | - | 1件: 97 97 💬
|
15 | 0.25mg RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
16 | 0.5 mg RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
17 | 1 mg RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
18 | 1 Serving of broccoli sprouts | 1件: Broccoli Broccoli | - | - | - | 1件: 97 97 💬
|
19 | 1.0 mg RPC103 | - | - | - | - | 1件: 97 97 💬
|
20 | 1.0 mg RPC1063 | - | - | - | - | 1件: 97 97 💬
|
21 | 1.Remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
22 | 10 mg Natura-alpha capsule | - | - | - | - | 1件: 97 97 💬
|
23 | 100 | - | - | - | - | 2件: 6 6, 97 💬
|
24 | 100 mg | - | - | - | - | 1件: 97 97 💬
|
25 | 14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | 3件: 13 13, 96, 97 💬
|
26 | 150 mg Induction/Chronic | - | - | - | - | 1件: 97 97 💬
|
27 | 1500mg mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
28 | 15N2-tofacitinib | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
29 | 2 x 10 mg Natura-alpha capsules | - | - | - | - | 1件: 97 97 💬
|
30 | 2'-Fucosyllactose | - | - | - | - | 2件: 96 96, 97 💬
|
31 | 2-Hydroxybenzoic acid | 1件: Salicylic acid Salicylic acid | 1件: Salicylic acid
Salicylic acid
💬
| - | - | 1件: 97 97 💬
|
32 | 20 mg | - | - | - | - | 1件: 97 97 💬
|
33 | 225mg SHP647 (PF-00547659) | - | - | - | - | 1件: 97 97 💬
|
34 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | 2件: 96 96, 97 💬
|
35 | 25 mg Ontamalimab | 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 💬
|
36 | 250mg mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
37 | 2L polyethylene glycol/ascorbic acid | 2件: Ascorbic acid Ascorbic acid, Polyethylene glycol | 2件: Ascorbic acid
Ascorbic acid
,
Polyethylene glycol 3350
💬
| - | - | 1件: 97 97 💬
|
38 | 3 Servings of broccoli sprouts | 1件: Broccoli Broccoli | - | - | - | 1件: 97 97 💬
|
39 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | 1件: Tromethamine Tromethamine | 1件: Tromethamine
Tromethamine
💬
| - | - | 2件: 96 96, 97 💬
|
40 | 331731-18-1 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
41 | 40 mg MSB11022 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
42 | 42942019 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
43 | 450 mg Induction/Chronic | - | - | - | - | 1件: 97 97 💬
|
44 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 💬
|
45 | 5-amino salicylic acid | 1件: Salicylic acid Salicylic acid | 1件: Salicylic acid
Salicylic acid
💬
| - | - | 1件: 97 97 💬
|
46 | 5-amino salicylic acid (5-ASA) | 2件: Mesalazine Mesalazine, Salicylic acid | 2件: Salicylic acid
Salicylic acid
,
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
47 | 5-amino-2-hydroxybenzoic acid | 1件: Salicylic acid Salicylic acid | 1件: Salicylic acid
Salicylic acid
💬
| - | - | 1件: 97 97 💬
|
48 | 5-Aminosalicyclic acid | - | - | - | - | 1件: 97 97 💬
|
49 | 5-aminosalicylate (Pentasa, Ferring) | - | - | - | - | 2件: 96 96, 97 💬
|
50 | 5-Aminosalicylic acid | 2件: Aminosalicylic acid Aminosalicylic acid, Mesalazine | 2件: Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
51 | 5-Aminosalicylic acid (5-ASA) | 2件: Aminosalicylic acid Aminosalicylic acid, Mesalazine | 2件: Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
52 | 5-ASA | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
53 | 5-ASA (5-Aminosalicylate) | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
54 | 5-ASA MMx | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
55 | 5-HTP | - | - | - | - | 2件: 96 96, 97 💬
|
56 | 50 mg | - | - | - | - | 1件: 97 97 💬
|
57 | 50 mg Induction/Chronic | - | - | - | - | 1件: 97 97 💬
|
58 | 500mg mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
59 | 549-0261/F02-01 | - | - | - | - | 2件: 96 96, 97 💬
|
60 | 6 Mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: HPRT1 HPRT1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
61 | 6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid | - | - | - | - | 1件: 97 97 💬
|
62 | 6-Mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: HPRT1 HPRT1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 3件: 96 96, 97, 164 💬
|
63 | 6-MP | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: HPRT1 HPRT1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
64 | 75 mg Ontamalimab | 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 💬
|
65 | 750mg mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
66 | 75mg SHP647 (PF-00547659) | - | - | - | - | 1件: 97 97 💬
|
67 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator | 3件: Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
68 | 90 mg idrocortisone acetato in supposta con appli | - | - | - | - | 1件: 97 97 💬
|
69 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | 1件: 97 97 💬
|
70 | [124I]IB PF 06687234 | - | - | - | - | 2件: 96 96, 97 💬
|
71 | [18F]FSPG | - | - | - | - | 2件: 96 96, 97 💬
|
72 | A multistrain probiotic product (DSF) | - | - | - | - | 1件: 97 97 💬
|
73 | A07DA03 | - | - | - | - | 1件: 97 97 💬
|
74 | A: 1 dosis | - | - | - | - | 1件: 97 97 💬
|
75 | AB (antibiotics) | - | - | - | - | 1件: 97 97 💬
|
76 | Abalimumab | - | - | - | - | 1件: 97 97 💬
|
77 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
78 | Abatacept (ABA) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 97 97 💬
|
79 | ABBV-006 | - | - | - | - | 1件: 97 97 💬
|
80 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 💬
|
81 | ABBV-323 | - | - | - | - | 2件: 53 53, 97 💬
|
82 | ABBV-323 Dose A | - | - | - | - | 1件: 97 97 💬
|
83 | ABBV-323 Dose B | - | - | - | - | 1件: 97 97 💬
|
84 | ABBV-668 | - | - | - | - | 1件: 97 97 💬
|
85 | AbGn-168H | - | - | - | - | 1件: 97 97 💬
|
86 | ABI-M201 | - | - | - | - | 1件: 97 97 💬
|
87 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: Abrilumab
Abrilumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
88 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 💬
|
89 | ABT-Humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
90 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
91 | ABX464 100mg | - | - | - | - | 2件: 46 46, 97 💬
|
92 | ABX464 25mg | - | - | - | - | 1件: 97 97 💬
|
93 | ABX464 50mg | - | - | - | - | 2件: 46 46, 97 💬
|
94 | Accelerated 1 hour-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
95 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
96 | Acetate | 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
|
97 | ACETATO DI AMMONIO | - | - | - | - | 1件: 97 97 💬
|
98 | Acetic acid | 1件: Acetic acid Acetic acid | 1件: Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | 1件: 97 97 💬
|
99 | Acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 2件: 6 6, 97 💬
|
100 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
101 | Adalimumab 40mg | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
102 | Adipate | 1件: Iron (III) oxide adipate Iron (III) oxide adipate | - | - | - | 2件: 97 97, 228 💬
|
103 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
104 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
105 | Adipose-cord mesenchymal stromal cells (A-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 97 97 💬
|
106 | AEB071 | - | - | - | - | 1件: 97 97 💬
|
107 | AEB071A | - | - | - | - | 1件: 97 97 💬
|
108 | AG011 | - | - | - | - | 1件: 97 97 💬
|
109 | AG011 - Capsules | - | - | - | - | 1件: 97 97 💬
|
110 | AG011 - Enema | - | - | - | - | 1件: 97 97 💬
|
111 | Air | - | - | - | - | 3件: 85 85, 97, 193 💬
|
112 | AJG501 | - | - | - | - | 1件: 97 97 💬
|
113 | AJG511 | - | - | - | - | 1件: 97 97 💬
|
114 | AJM300 | - | - | - | - | 1件: 97 97 💬
|
115 | AL | - | - | - | - | 11件: 5 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬
|
116 | ALDESLEUKIN | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬
| 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 49 49, 65, 96, 97 💬
|
117 | Algin | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬
| - | - | 1件: 97 97 💬
|
118 | Alicaforsen | 1件: Alicaforsen Alicaforsen | - | - | - | 2件: 96 96, 97 💬
|
119 | Alkaline Phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 4件: 46 46, 93, 97, 172 💬
|
120 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
121 | Allopurinol | 1件: Allopurinol Allopurinol | 1件: Allopurinol
Allopurinol
💬
| 1件: XDH XDH 💬
| 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
122 | AloASC | - | - | - | - | 1件: 97 97 💬
|
123 | Aloe | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 2件: 97 97, 226 💬
|
124 | Aloe Barbadensis Miller | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 💬
|
125 | Aloe vera | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 2件: 97 97, 226 💬
|
126 | Aloe vera gel | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 💬
|
127 | Also referred to as 'MEDI2070' | - | - | - | - | 2件: 96 96, 97 💬
|
128 | Also referred to as MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
129 | ALTH12-1:4 | - | - | - | - | 1件: 97 97 💬
|
130 | ALTH12-2:4 | - | - | - | - | 1件: 97 97 💬
|
131 | AMG 181 | - | - | - | - | 2件: 96 96, 97 💬
|
132 | AMG 592 | - | - | - | - | 3件: 46 46, 49, 97 💬
|
133 | AMG181 | - | - | - | - | 1件: 97 97 💬
|
134 | Amgevita | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
135 | AMGEVITA (Adalimumab biosimilar ) | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
136 | Amgevita 40 mg Injektionslösung im Fertigpen | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
137 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
138 | Amgevita 40Mg Solution for Injection | - | - | - | - | 2件: 96 96, 97 💬
|
139 | AMGEVITA® | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
140 | AMINOSALICYLIC ACID | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | 2件: 96 96, 97 💬
|
141 | Amiselimod | 1件: Amiselimod Amiselimod | 1件: Amiselimod
Amiselimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 97 97 💬
|
142 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 1件: Amitriptyline
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 78 78, 97, 226, 299 💬
|
143 | Amitriptyline hydrochloride | 1件: Amitriptyline Amitriptyline | 1件: Amitriptyline
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 97 97 💬
|
144 | Amoxicillin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 7件: 6 6, 46, 63, 96, 97, 222, 299 💬
|
145 | Amoxicillin and doxycyclin | 2件: Amoxicillin Amoxicillin, Doxycycline | 4件: Amoxicillin
Amoxicillin
,
Doxycycline
,
Amoxicillin
,
Doxycycline
💬
| - | - | 1件: 97 97 💬
|
146 | Amoxicillin, metronidazole and doxycycline | 3件: Amoxicillin Amoxicillin, Doxycycline, Metronidazole | 5件: Amoxicillin
Amoxicillin
,
Doxycycline
,
Metronidazole
,
Amoxicillin
,
Doxycycline
💬
| - | - | 1件: 97 97 💬
|
147 | AMT | - | - | - | - | 4件: 8 8, 46, 97, 321 💬
|
148 | AMT-101 | - | - | - | - | 2件: 46 46, 97 💬
|
149 | AMT-101 (oral) | - | - | - | - | 1件: 97 97 💬
|
150 | Anakinra | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 16件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
|
151 | AND (Andrographolide) | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 💬
|
152 | Andecaliximab | - | - | - | - | 4件: 46 46, 96, 97, 299 💬
|
153 | AndoSan | - | - | - | - | 2件: 96 96, 97 💬
|
154 | ANDROGRAPHIS PANICULATA | - | - | - | - | 1件: 97 97 💬
|
155 | ANDROGRAPHIS PANICULATA (ethanol extract) | 1件: Ethanol Ethanol | 1件: Ethanol
Ethanol
💬
| - | - | 1件: 97 97 💬
|
156 | Andrographolide | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 💬
|
157 | Anrukinzumab | 1件: Anrukinzumab Anrukinzumab | 1件: Anrukinzumab
Anrukinzumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 97 97 💬
|
158 | Anti Beta7 | - | - | - | - | 1件: 97 97 💬
|
159 | Anti CD3 monoclonal antibody | - | - | - | - | 1件: 97 97 💬
|
160 | Anti TNF therapy including infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
161 | Anti-CD3 | 1件: Muromonab Muromonab | - | - | - | 2件: 96 96, 97 💬
|
162 | Anti-CD3 Monoclonal antibody | 1件: Muromonab Muromonab | - | - | - | 2件: 96 96, 97 💬
|
163 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | 2件: 96 96, 97 💬
|
164 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | 2件: 96 96, 97 💬
|
165 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | 2件: 96 96, 97 💬
|
166 | Anti-IP-10 Antibody | - | - | - | - | 1件: 97 97 💬
|
167 | Anti-MAdCAM antibody | - | - | - | - | 2件: 96 96, 97 💬
|
168 | Anti-TL1A | - | - | - | - | 1件: 97 97 💬
|
169 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | 2件: 96 96, 97 💬
|
170 | Anti-TNF Drug | - | - | - | - | 2件: 96 96, 97 💬
|
171 | Anti-TNF therapy | - | - | - | - | 3件: 46 46, 96, 97 💬
|
172 | Anti-TNF: Infliximab (Infusion) | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
173 | Anti-TNF:Adalimumab (Subcutaneus) | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
174 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 💬
|
175 | AODG (Apigenin-7-O-glucuronide) | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 💬
|
176 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 💬
|
177 | APD334 L-arginine | 2件: Arginine Arginine, L-arginine | 1件: Arginine
Arginine
💬
| - | - | 1件: 97 97 💬
|
178 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 2件: 6 6, 97 💬
|
179 | APL-1401 | - | - | - | - | 1件: 97 97 💬
|
180 | Apremilast | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 💬
|
181 | Apriso 0.375G ER CAP | - | - | - | - | 1件: 97 97 💬
|
182 | APRISO 375 mg extended-release capsules | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 97 97 💬
|
183 | APVO210 | - | - | - | - | 1件: 97 97 💬
|
184 | Aquamin | - | - | - | - | 1件: 97 97 💬
|
185 | Aquamin® | - | - | - | - | 1件: 97 97 💬
|
186 | AR401959 L-arginine | 2件: Arginine Arginine, L-arginine | 1件: Arginine
Arginine
💬
| - | - | 3件: 96 96, 97, 98 💬
|
187 | Arginine | 1件: Arginine Arginine | 1件: Arginine
Arginine
💬
| - | - | 11件: 46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 💬
|
188 | ASA | - | - | - | - | 3件: 13 13, 97, 251 💬
|
189 | ASACOL | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
190 | Asacol (mesalamine) | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
191 | Asacol (mesalamine) Delayed-release Tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
192 | Asacol 400 mg | - | - | - | - | 1件: 97 97 💬
|
193 | Asacol 400 mg (mesalamine) | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
194 | Asacol 400 mg tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
195 | Asacol 400mg tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
196 | Asacol 800 mg (mesalamine) | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
197 | Asacol 800 mg tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
198 | Asacol 800mg tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
199 | Asacol Delayed Release Tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
200 | Asacol Delayed-Release Tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
201 | Asacol tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
202 | Asacol® | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
203 | Asacol® 400 mg | - | - | - | - | 1件: 97 97 💬
|
204 | ASC | - | - | - | - | 4件: 36 36, 51, 96, 97 💬
|
205 | Ascorbic acid | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 4件: 10 10, 97, 206, 298 💬
|
206 | ASP015K | - | - | - | - | 2件: 46 46, 97 💬
|
207 | ASP3291 | - | - | - | - | 1件: 97 97 💬
|
208 | Aspergillus oryzae | 1件: Aspergillus oryzae Aspergillus oryzae | - | - | - | 1件: 97 97 💬
|
209 | AST-120 | - | - | - | - | 2件: 96 96, 97 💬
|
210 | ATL-2502 | 1件: ATL-2502 ATL-2502 | - | - | - | 1件: 97 97 💬
|
211 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 1件: Atorvastatin
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
212 | Atorvastatin 80mg | 1件: Atorvastatin Atorvastatin | 1件: Atorvastatin
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 97 97 💬
|
213 | Atorvastatin Calcium | 2件: Atorvastatin Atorvastatin, Calcium | 1件: Atorvastatin
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 97 97, 265 💬
|
214 | AVONEX | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 💬
|
215 | AVX 470 | - | - | - | - | 1件: 97 97 💬
|
216 | AZA | - | - | - | - | 4件: 11 11, 40, 96, 97 💬
|
217 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | 1件: 97 97 💬
|
218 | AZAFOR 50mg | - | - | - | - | 1件: 97 97 💬
|
219 | Azathioprine | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬
|
220 | Azathioprine (AZA) | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬
| - | - | 3件: 13 13, 19, 97 💬
|
221 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | 2件: Azathioprine Azathioprine, Mercaptopurine | 3件: Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Mercaptopurine
💬
| 1件: HPRT1 HPRT1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
222 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬
| - | - | 1件: 97 97 💬
|
223 | Azathioprine and Allopurinol | 2件: Allopurinol Allopurinol, Azathioprine | 2件: Allopurinol
Allopurinol
,
Azathioprine
💬
| 1件: XDH XDH 💬
| 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 1件: 97 97 💬
|
224 | AZATHIOPRINE BP | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬
| - | - | 1件: 97 97 💬
|
225 | Azathioprine or 6-mercaptopurine | 2件: Azathioprine Azathioprine, Mercaptopurine | 3件: Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Mercaptopurine
💬
| 1件: HPRT1 HPRT1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
226 | Azatioprina | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬
| - | - | 3件: 13 13, 96, 97 💬
|
227 | B2-ASmedic | - | - | - | - | 1件: 97 97 💬
|
228 | B: 2 dosis | - | - | - | - | 1件: 97 97 💬
|
229 | Bacteriotherapy | - | - | - | - | 2件: 96 96, 97 💬
|
230 | Balsalazide | 1件: Balsalazide Balsalazide | 1件: Balsalazide
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
231 | Balsalazide Disodium | 1件: Balsalazide Balsalazide | 1件: Balsalazide
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
232 | Baminercept | 1件: Baminercept Baminercept | 1件: Baminercept
Baminercept
💬
| 1件: LTB LTB 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 53, 97 💬
|
233 | Bascial prescription plus or minus herbs depend on symptoms | - | - | - | - | 1件: 97 97 💬
|
234 | Basiliximab | 1件: Basiliximab Basiliximab | 1件: Basiliximab
Basiliximab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 50, 97, 222, 228 💬
|
235 | BBT-401-1S | - | - | - | - | 1件: 97 97 💬
|
236 | BBT-401-1S, Multiple doses | - | - | - | - | 1件: 97 97 💬
|
237 | BBT-401-1S, Single dose | - | - | - | - | 1件: 97 97 💬
|
238 | Beclometasone | - | - | - | - | 1件: 97 97 💬
|
239 | Beclometasone dipropionate | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 85 85, 97 💬
|
240 | Beclomethasone dipropionate | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 98 💬
|
241 | Beclomethasone diproprionate | - | - | - | - | 1件: 97 97 💬
|
242 | Berberine | 1件: Berberine Berberine | - | - | - | 2件: 97 97, 265 💬
|
243 | Berberine Chloride | 2件: Berberine Berberine, Chloride ion | - | - | - | 1件: 97 97 💬
|
244 | Bertilimumab | - | - | - | - | 2件: 97 97, 162 💬
|
245 | Beta-1,3/1,6-D-Glucan | - | - | - | - | 1件: 97 97 💬
|
246 | Bezlotoxumab | 1件: Bezlotoxumab Bezlotoxumab | 1件: Bezlotoxumab
Bezlotoxumab
💬
| - | - | 2件: 96 96, 97 💬
|
247 | BG9418 (interferon beta-1a) | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 💬
|
248 | BG9924 | - | - | - | - | 2件: 46 46, 97 💬
|
249 | BGP-014 | - | - | - | - | 1件: 97 97 💬
|
250 | BGP-014 Capsules | - | - | - | - | 1件: 97 97 💬
|
251 | BI 655130 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
252 | BIAP | - | - | - | - | 2件: 46 46, 97 💬
|
253 | Bifidobacterium breve | 1件: Bifidobacterium breve Bifidobacterium breve | - | - | - | 1件: 97 97 💬
|
254 | Bifidobacterium infantis | 1件: Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | 2件: 96 96, 97 💬
|
255 | Bifidobacterium infantis 35624 | 1件: Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | 2件: 96 96, 97 💬
|
256 | BIMEKIZUMAB | 1件: Bimekizumab Bimekizumab | 1件: Bimekizumab
Bimekizumab
💬
| 2件: IL17A IL17A, IL17F 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 46 46, 97, 271 💬
|
257 | Bio-enhanced Curcumin Soft Gelatin Capsule | 2件: Curcumin Curcumin, Gelatin | 2件: Gelatin
Gelatin
,
Donkey glue
💬
| - | - | 1件: 97 97 💬
|
258 | Biological Drug | - | - | - | - | 3件: 46 46, 96, 97 💬
|
259 | Biologically active human fecal microbiota | - | - | - | - | 1件: 97 97 💬
|
260 | Biologics | - | - | - | - | 3件: 46 46, 96, 97 💬
|
261 | Biopsies | - | - | - | - | 1件: 97 97 💬
|
262 | Biosimilar | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
263 | Biosimilar Infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
264 | BITTER CANDYTUFT FRESH PLANT EXTRACT | - | - | - | - | 1件: 97 97 💬
|
265 | Bitterschleifenblume-ganzpflanze 1,5ml/10ml | - | - | - | - | 1件: 97 97 💬
|
266 | BL-7040 | - | - | - | - | 1件: 97 97 💬
|
267 | Blood sample | - | - | - | - | 20件: 8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 💬
|
268 | Blood samples | - | - | - | - | 9件: 13 13, 41, 51, 61, 97, 227, 240, 271, 280 💬
|
269 | BMS-188667 | - | - | - | - | 9件: 46 46, 49, 53, 65, 96, 97, 107, 222, 271 💬
|
270 | BMS-936557 | - | - | - | - | 2件: 96 96, 97 💬
|
271 | BMS-986165 | - | - | - | - | 3件: 49 49, 96, 97 💬
|
272 | BMS-986166 | - | - | - | - | 1件: 97 97 💬
|
273 | BMS-986184 | - | - | - | - | 1件: 97 97 💬
|
274 | BMS986165 | - | - | - | - | 2件: 96 96, 97 💬
|
275 | Boulardii | - | - | - | - | 2件: 96 96, 97 💬
|
276 | Bovine intestinal alkaline phosphatase (BIAP) | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬
|
277 | Bovine-Calf Alkaline Phosphatase (BIAP) | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬
|
278 | Bovine-Calf Alkaline Phosphatase BIAP | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬
|
279 | BRAZIKUMAB | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
280 | Brazikumab Induction Dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
281 | Brazikumab Maintenance Dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
282 | Brepocitinib 25 mg | - | - | - | - | 2件: 96 96, 97 💬
|
283 | Brepocitinib 5 mg | - | - | - | - | 2件: 96 96, 97 💬
|
284 | Broccoli | 1件: Broccoli Broccoli | - | - | - | 3件: 36 36, 97, 299 💬
|
285 | BT | - | - | - | - | 3件: 96 96, 97, 98 💬
|
286 | BT-11 | - | - | - | - | 2件: 96 96, 97 💬
|
287 | BT-11 (1000 mg) | - | - | - | - | 1件: 97 97 💬
|
288 | BT-11 (500 mg) | - | - | - | - | 1件: 97 97 💬
|
289 | BT-11 1000mg | - | - | - | - | 3件: 96 96, 97, 98 💬
|
290 | BT-11 500 mg | - | - | - | - | 2件: 96 96, 97 💬
|
291 | BT-11 Active | - | - | - | - | 2件: 96 96, 97 💬
|
292 | BT051 200 mg | - | - | - | - | 1件: 97 97 💬
|
293 | BT051 3200 mg | - | - | - | - | 1件: 97 97 💬
|
294 | BT051 800 mg | - | - | - | - | 1件: 97 97 💬
|
295 | Budenofalk 2mg rectal foam | - | - | - | - | 1件: 97 97 💬
|
296 | Budenofalk 3mg | - | - | - | - | 2件: 93 93, 97 💬
|
297 | Budenofalk rectal foam | - | - | - | - | 1件: 97 97 💬
|
298 | Budenofalk® suppositories | - | - | - | - | 1件: 97 97 💬
|
299 | Budenofalk® suppositories (BUS) | - | - | - | - | 1件: 97 97 💬
|
300 | BUDESONIDE | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
|
301 | Budesonide (6 mg) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
302 | Budesonide (9 mg) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
303 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
304 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
305 | Budesonide 9 mg capsules, hard (BUX-PV) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
306 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
307 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
308 | Budesonide MMX | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
309 | Budesonide MMX 6 mg Tablet | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
310 | Budesonide MMX® | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
311 | Budesonide MMX® 6 mg | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
312 | Budesonide MMX® 9 mg | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
313 | Budesonide-MMX | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
314 | Budesonide-MMX® | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
315 | Budesonide-MMX® 6 mg | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
316 | Budesonide-MMX® 9 mg | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
317 | Budesonide-MMX™ | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
318 | Butanoic acid | 1件: Butyric Acid Butyric Acid | - | - | - | 3件: 34 34, 51, 97 💬 |